- Tele2’s EBITDA for Q1 was SEK 2.84 billion, slightly below the estimated SEK 2.94 billion.
- The company’s Adjusted EBITDA after leases was SEK 2.71 billion, surpassing the forecast of SEK 2.64 billion.
- Tele2 recorded Adjusted EBITDA of SEK 3.13 billion, exceeding the SEK 3.01 billion estimate.
- Net sales were SEK 7.15 billion, falling short of the expected SEK 7.28 billion.
- Strong performance in the Baltic region and improved cost discipline contributed to a 6% year-over-year increase in Underlying EBITDAaL.
- The organization is undergoing a cultural shift towards greater cost-consciousness, scrutinizing purchases and reviewing its 350 largest contracts.
- Analysts’ recommendations include 11 buys, 12 holds, and 3 sells.
A look at Tele2 AB Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 3 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts using the Smartkarma Smart Scores system have evaluated Tele2 AB, a telecommunications company with operations across Europe and EuroAsia. The scores indicate a mixed outlook for the company’s long-term performance. Tele2 AB received a strong score of 5 for its dividend, suggesting a robust dividend policy that may be attractive to income-oriented investors. Momentum also received a high score of 5, indicating positive market trends that could drive the company’s stock performance.
However, Tele2 AB scored lower in other areas essential for long-term growth. With a value score of 2, the company may not be considered significantly undervalued by the market. In terms of growth and resilience, Tele2 AB received scores of 3, reflecting moderate prospects in these areas. Investors looking at Tele2 AB should consider these Smart Scores as part of a comprehensive analysis before making any investment decisions.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
